Cvs Health Corp (CVS) EVP, ENT STRATEGY & DIGITAL Joshua Matthew Flum Sold $1.1 million of Shares (Guru Focus)
EVP, ENT STRATEGY & DIGITAL of CVS Health Corp., Joshua Matthew Flum, sold 17,703 shares of CVS on 09/30/2019 at an average price of $63 a share. The total sale was $1.1 million. CVS Health Corp operates in the healthcare sector. Its primary business is that of operating retail pharmacies. The company has three reportable segments namely Pharmacy Services, Retail/LTC, and Corporate. CVS Health Corp has a market cap of $81.09 billion; its shares were traded at around $62.35 with a P/E ratio of 17.48 and P/S ratio of 0.33.
SEC Charges Northbrook Hedge Fund Execs with Fraud (MooseGazette.net)
Two executives at a Northbrook hedge fund have been billed with fraud after allegedly dishonest shoppers out of more than a million pounds. Samuel Barnett and Matthew Aven, top rated executives at SBB Investigate Team, LLC, made use of their possess valuation design to inflate the price of their investments, the Securities and Exchange Commission mentioned. The pair used that product to misstate the fund’s historical performance and overcharged investors about $1.4 million in charges, the SEC mentioned.
SEC Obtains Final Judgment Against Investment Banker Charged in Insider Trading Scheme (STL.News.com)
(STL.News) – On September 30, 2019, a federal court judge entered a final judgment in the SEC’s action against Woojae (“Steve”) Jung, a former employee of a prominent investment bank charged with repeatedly using his access to highly confidential information in order to place illicit and profitable trades in advance of deals on which the bank was providing investment banking services. The SEC filed its action in May 2018 and Jung was also charged criminally by the U.S. Attorney’s Office for the Southern District of New York. In the parallel criminal case, Jung pled guilty to securities fraud and was sentenced to a term of incarceration of 3 months, forfeiture to the United States in the amount of $130,000, a $30,000 fine, and 2 years of supervised release.
Aurobindo Co-Founder Hit With $3m Fine For Insider Trading (Pharma Intelligence Informa)
Indian stock market regulator SEBI has slapped the billionaire founder of Aurobindo Pharma, along with other promoters of the company, with a more than $3m fine for allegedly violating insider trading norms over a string of licensing agreements with multinational Pfizer.
CFTC Orders Six Financial Institutions to Pay Total of More Than $6 Million for Reporting Failures (HedgeCo.net)
(HedgeCo.Net) The U.S. Commodity Futures Trading Commission today announced that it issued orders yesterday against HSBC Bank USA, N.A., Société Générale International Limited, The Northern Trust Company, NatWest Markets Plc, The Bank of New York Mellon, and PNC Bank, National Association for reporting failures. Société Générale International Limited and The Northern Trust Company were also charged with failing to supervise in connection with the reporting failures. HSBC was also charged with violating swap-dealer risk management regulations, the first time the Commission has brought such an action. “Accurate reporting is essential to effective fulfillment of the regulatory functions of the CFTC, including meaningful surveillance and enforcement programs,” said CFTC Director of Enforcement James McDonald. “As these actions show, the CFTC will continue to vigorously enforce reporting requirements. The CFTC will also take appropriate action where reporting failures are occurring as a result of serious supervisory failures.”
Daily Insider Ratings Round Up 9/30/19 (Seeking Alpha)
On Today’s Tables: Insider trades were rated Significant at: Ulta Beauty (ULTA); Occidental Petroleum (OXY), and; Anterix (ATEX). Insider trades were rated Nearly Significant at: Provention Bio (PRVB), and; FlexShopper (FPAY).
